Study of Anxiety After a Session of Energy Resonance by Cutaneous Stimulation

NCT ID: NCT06056414

Last Updated: 2026-01-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

57 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-08

Study Completion Date

2025-07-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Performing a breast macrobiopsy can be extremely delicate and anxiety-provoking. It can have an impact on the course of future examinations.

Patients' emotional feelings also have a definite impact on the nursing staff. The purpose of the MBRESC study is to evaluate Energy Resonance by Cutaneous Stimulation , a manual acupressure technique, in the management of anxiety prior to breast macrobiopsy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Neoplasm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Energy Resonance by Cutaneous Stimulation

one Energy Resonance by Cutaneous Stimulation session performed before macrobiopsy

Group Type EXPERIMENTAL

Energy Resonance by Cutaneous Stimulation

Intervention Type OTHER

Energy Resonance by Cutaneous Stimulation session

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Energy Resonance by Cutaneous Stimulation

Energy Resonance by Cutaneous Stimulation session

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient has received full information on the organization and purpose of the research, and has signed an informed consent form.
* Patient over 18 years of age
* Patient undergoing a diagnostic breast macrobiopsy for suspected breast cancer
* Patient undergoing a macro breast biopsy for the first time
* Patient affiliated to or benefiting from a social security schem

Exclusion Criteria

* Patient with a history of breast cancer or other pathologies requiring invasive procedures
* Patient with several lesions to be biopsied
* Patient with psychiatric pathology
* Patient under anxiolytic or psychotropic treatment initiated in the month before the breast macrobiopsy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Henri Becquerel

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Celine Lemaire

Role: PRINCIPAL_INVESTIGATOR

Centre Henri Becquerel

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Henri Becquerel

Rouen, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHB23.02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.